Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Arnold & Porter ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6  
>>Next
 
Title
Country
Organisation
Author
Date
1
Pharmaceutical Companies: Beware Of Revocation Of EU Trade Marks For Lack Of ‘Genuine Use' During Clinical Trials
Viridis's use of the BOSWELAN mark during the clinical trial was purely internal in nature.
European Union
9 Oct 2019
2
The Trump Administration Drug Importation Action Plan
In the past, such proposals have largely been met with resistance by the FDA.
United States
5 Aug 2019
3
Update On The Implementation Of The European Medical Devices Regulation And In Vitro Diagnostics Regulation
On May 26, 2017, the new European Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) entered into force.
European Union
2 Aug 2019
5
New Guidance Under The EU MDR
The guidance does not clarify if the same PRRC can act for multiple manufactures.
European Union
12 Jul 2019
6
Update On The European MDR And IVDR (June 2019)
We set out below an update on the current state of play.
European Union
10 Jul 2019
7
Lit Alerts—July 2019
The Second Circuit Court of Appeals recently affirmed the SDNY'S dismissal of suits against Bristol-Myers Squibb Co. and Pfizer Inc. on the ground that the suits asserted state-law claims that were preempted by the FDCA.
United States
5 Jul 2019
8
The Chemical Compound—July 2019
This quarterly newsletter provides updates on litigation, regulatory, legislative, and other notable developments involving chemicals of concern to business.
United States
5 Jul 2019
9
Localization Barriers To Trade In Medicines And Health Care Products: The Tricky Business Of Balancing Competing Interests
He also highlights the increasingly challenging political and economic environment faced by industries.
UK
5 Jul 2019
10
EMA Releases Draft Guidelines On Drug-Device Combinations
DDCs are human medicines that include a medical device.
European Union
19 Jun 2019
11
Supreme Court Puts New Spin On Preemption Analysis
On May 28, 2019, just a week after deciding Merck, the Supreme Court denied certiorari, letting that preemption decision stand.
United States
4 Jun 2019
12
Join The Next Future Pharma Forum: Competition/Antitrust Seminar, 13 June
The Arnold & Porter Future Pharma Forum provides training and networking opportunities for junior and mid-level lawyers in the life sciences industry.
UK
23 May 2019
13
Join Our Webinar On 18 June To Discuss Data And Its Impact On Medical Technology Companies
Apologies that it has been a while since we've posted! We have lots in the pipeline, starting with this webinar.
UK
23 May 2019
14
Pippins Quoted In Natural Products Insider On FDA Regulatory Issues
She also discussed how the recent departure of Commissioner Scott Gottlieb from the FDA will impact the consumer products industry.
United States
23 Apr 2019
15
EU Regulation Of CBD In Foods And Cosmetics
A new date for the vote has not been set yet.
Worldwide
16 Apr 2019
16
Mulryne Quoted In The Pink Sheet On Brexit Ramifications For Pharmaceutical Industry
The article considers how UK-based life sciences companies can prepare for the UK's departure from the EU despite uncertainty surrounding the UK's unconfirmed exit deal.
UK
16 Apr 2019
17
Life Sciences (UK) 2019
The regulation of medicinal products in the UK derives from EU legislation, principally Directive 2001/83/EC (the Directive), and Regulation (EC) 726/2004 (the EU Regulation).
UK
15 Apr 2019
18
European Competition Enforcement In The Pharmaceutical Sector: More To Be Expected?
On 28 January 2019, the European Commission (Commission) published its Report to the Council and the European Parliament on Competition Enforcement in the pharmaceutical Sector (2009-2017) (Report).
United States
26 Mar 2019
19
Impact Of UK's Temporary Tariff Regime On Life Sciences
This is being published ahead of the vote in Parliament on no deal to ensure that the members of parliament are well informed.
European Union
26 Mar 2019
20
FDA, State, And Local Governments Act To Modernize The Regulation Of Sunscreen Products In The United States
In February 26, 2019, FDA published its long-awaited proposed rule, Sunscreen Products for Over-the-Counter Human Use (Proposed Rule).
United States
15 Mar 2019
Links to Result pages
 
1 2 3 4 5 6  
>>Next